Advertisement

ERCP Features

  • Terumi Kamisawa
Chapter

Abstract

Lymphoplasmacytic infiltration and fibrosis are primarily subepithelial around the pancreatic duct in patients with autoimmune pancreatitis (AIP). This process encompasses the pancreatic ducts and narrows their lumen. Diffuse irregular narrowing of the main pancreatic duct (MPD) is rather specific to AIP. Pancreatic cancer typically infiltrates and destroys the epithelium of the pancreatic duct. These periductal histopathological differences result in the variance in pancreatographic findings between AIP and pancreatic cancer. Pancreatographic findings such as absence of obstruction of the MPD, skip lesions of the MPD, side branch derivation from the narrowed portion of the MPD, MPD involvement over >3 cm, and maximal upstream MPD diameter of <5 mm are each suggestive of AIP. However, it is difficult to differentiate a short narrowing of the MPD in AIP from stenosis in pancreatic cancer, and there are some pancreatic cancer cases showing pancreatographic findings similar to those of AIP. MRCP does not replace ERCP in initial diagnosis from the inability to reliably detect MPD narrowing due to the inferior resolution, but may have a role in the follow-up of AIP patients. IgG4 immunostaining of biopsy specimens obtained from the major duodenal papilla is useful for supporting a diagnosis of AIP.

Keywords

Pancreatic Cancer Main Pancreatic Duct Obstructive Jaundice Pancreatic Cancer Patient Hilar Bile Duct 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Toki F, Kozu T, Oi I, et al. An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP – a report of four cases. Endoscopy. 1992;24:640.Google Scholar
  2. 2.
    Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Okazaki K, Kawa S, Kamisawa T, et al. Japanese consensus guidelines for autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2010;45:249–65.PubMedCrossRefGoogle Scholar
  5. 5.
    Kamisawa T, Anjiki H, Takuma K, et al. Endoscopic approach for diagnosing autoimmune pancreatitis. World J Gastrointest Endosc. 2010;2:20–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Kamisawa T, Imai M, Chen PY, et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas. 2008;37:e62–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52:683–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Kloppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T. Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol. 2007;42(Suppl):28–31.PubMedCrossRefGoogle Scholar
  9. 9.
    Chandan VS, Iacobuzio-Donalue C, Abraham SC. Patchy distribution of pathologic abnormalities in autoimmune pancreatitis. Implications for preoperative diagnosis. Am J Surg Pathol. 2008;32:1762–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Nishino T, Oyama H, Toki F, et al. Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol. 2010;45:988–96.PubMedCrossRefGoogle Scholar
  11. 11.
    Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut. 2011;60:666–70.Google Scholar
  12. 12.
    Takuma K, Kamisawa T, Tabata T, et al. Utility of pancreatography for diagnosing autoimmune pancreatitis. World J Gastroenterol. 2011;17:2332–7.Google Scholar
  13. 13.
    Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol. 2008;43:403–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Park SH, Kim MH, Kim SY, et al. Magnetic resonance cholangiopancreatography for the diagnostic evaluation of autoimmune pancreatitis. Pancreas. 2010;39:1191–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Carbognin G, Girardi V, Biasiutti C, et al. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. Radiol Med. 2009;114:1214–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Kamisawa T, Takuma K, Egawa N, et al. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010;7:401–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Kamisawa T, Tu Y, Egawa N, et al. A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endosc. 2008;68:358–61.PubMedCrossRefGoogle Scholar
  19. 19.
    Kim MH, Moon SH, Kamisawa T. Major duodenal papilla in autoimmune pancreatitis. Dig Surg. 2010;27:110–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Internal MedicineTokyo Metropolitan Komagome HospitalBunkyo-ku/TokyoJapan

Personalised recommendations